Treatment
68Ga-FAPI clinical trials
We’re tracking 37 recruiting studies that include 68Ga-FAPI, each written for real people, not researchers, below.
Recruiting studies
- NCT07753499Recruiting
PET scan for recurrent or metastatic thyroid cancer
This study tests a new type of PET scan to find thyroid cancer that has come back or spread. It compares two tracers to see which one better shows the cancer, which may help doctors choose the right treatment.
Xiamen, FujianAges 18–90 - NCT06659705RecruitingPhase 2
New PET scan for early pancreatic cancer detection
This trial tests a new type of PET scan that uses a special tracer (FAPI) to get clearer images of pancreatic cancer. The goal is to find cancer earlier and better plan surgery or treatment.
Saint-CloudAges 18 years+ - NCT05400967RecruitingEarly Phase 1
Scan metastatic tumors and test targeted radiation treatment
This trial looks at whether a special PET scan can find metastatic tumors and guide a targeted radiation treatment. It may help people by improving how doctors locate tumors and decide where to deliver therapy.
Beijing, Beijing MunicipalityAges 18–80 - NCT06790264Recruiting
Special PET Scan for Breast Cancer - FAPi Imaging
This trial uses a special PET scan (68Ga-FAPi-46) to see how breast cancer interacts with nearby cells. It may help doctors understand your tumor better and guide treatment decisions, especially if you are planning surgery or chemotherapy before surgery.
Milan, ItalyAges 18 years+ - NCT05034146Recruiting
Ga-FAPI PET/CT scan for people with cancer
This study tests how useful a special PET/CT scan (called 68Ga-FAPI) is for people who may have or have been diagnosed with cancer. The scan may help doctors see cancer activity more clearly.
Wuhan, HubeiAges 18–88 - NCT05121779RecruitingPhase 1
PET-CT scan compares two tests for lung scarring
This early (Phase 1) study compares two types of PET-CT scans to see how well they detect and measure lung scarring (pulmonary fibrosis). It may help doctors choose the best scan test for diagnosis in the future.
Beijing, Beijing MunicipalityAges 18–80 - NCT05172310RecruitingPhase 1
PET scan study using a new tracer for solid tumors
This trial tests a special PET/CT scan using a new tracer (68Ga-FAPI) to help show tumors in the pancreas, bile ducts, stomach, or certain ovarian cancers. It may help doctors better see where cancer is in preparation for surgery or biopsy.
StockholmAges 19 years+ - NCT05543954RecruitingEarly Phase 1
PET/CT scan test to see lung cancer using a new tracer
This early-phase study tests a special whole-body scan (PET/CT) that uses injected tracers to help show where lung cancer may be. It may help researchers see tumors more clearly and compare different tracers during the same time window.
BeijingAges 18 years+ - NCT06151119Recruiting
PET scan test for myelofibrosis using a special tracer
This study uses a new type of PET/CT scan with a tracer called 68Ga-FAPI to help diagnose myelofibrosis, see how advanced it is, and check if treatment is working. It may help doctors better understand your condition and plan your care.
Xiamen, FujianAges 18 years+ - NCT06232122Recruiting
New PET scans to detect ovarian cancer recurrence
This study uses two types of PET/CT scans (68Ga-FAPI-46 and 18F-FDG) to look for any returning ovarian cancer. The goal is to find recurrence early so you and your doctor can plan the next steps.
Taoyuan CityAges 30–80 - NCT06335069RecruitingPhase 2
Comparing two PET tracers in ER-positive breast cancer
This trial compares two types of PET scans to see which one better detects ER-positive breast cancer. The results could help doctors choose the best scan for tracking your cancer.
MaastrichtAges 18 years+ - NCT06349512Recruiting
PET scan to predict treatment response in triple-negative breast cancer
This trial uses a special PET scan (68Ga-FAPI-46) to see if it can predict how well chemotherapy plus immunotherapy (pembrolizumab) works in people with triple-negative breast cancer before surgery. It aims to help doctors understand if the treatment is effective earlier.
AntonyAges 18 years+ - NCT06455761RecruitingEarly Phase 1
PET scan with a new tracer for solid tumors
This trial uses a special PET scan (68Ga-DOTA-NI-FAPI04) to get clearer images of various solid tumors. It may help doctors see your cancer better and plan your treatment.
FuzhouAges 18–80 - NCT06740240RecruitingEarly Phase 1
68Ga-FAPI-Biotin PET/CT scan for cancer imaging
This trial tests a new PET/CT scan that uses a special tracer (68Ga-FAPI-Biotin) to help detect and see various solid tumors. It may provide more detailed images to guide treatment decisions.
FuzhouAges 18–90 - NCT07062523RecruitingPhase 1/Phase 2
FAPI PET scan for Sjögren's syndrome inflammation
This study uses a special PET scan (FAPI PET) to look at inflammation in people with Sjögren's syndrome. It helps doctors understand how active the disease is. You may join if you have Sjögren's syndrome or a solid tumor that needs this scan, and you are not on certain medications.
BeijingAges 18–80 - NCT07138729Recruiting
Imaging test for rheumatoid arthritis inflammation
This trial tests a new imaging scan (SPECT) that uses a special tracer (99mTc-TCR-FAPI) to see inflammation in the joints of people with rheumatoid arthritis. It aims to help doctors better understand and track disease activity.
Beijing, Beijing MunicipalityAges 18–75 - NCT07083011RecruitingPhase 2
PET scan study for heart failure and cardiac sarcoidosis
This study uses a special PET scan (68Ga-FAPI) to look at inflammation in the heart. It may help researchers understand heart failure and cardiac sarcoidosis better.
Rochester, MinnesotaAges 18 years+ - NCT06409585Recruiting
Heart muscle disease imaging study for scarring
This study uses advanced imaging (PET/MR or PET/CT) to look at scarring (fibrosis) in the heart muscle. It is for people with various heart muscle diseases, including heart failure with preserved pumping, thickened heart muscle, high blood pressure-related heart damage, heart inflammation, and others.
Edinburgh, ScotlandAges 30–90 - NCT07684924Recruiting
Early FAPI PET/MRI after a heart attack
This study uses a new type of PET/MR scan (FAPI) to look at inflammation in the heart shortly after a heart attack. It may help doctors understand recovery better and guide future treatments.
AnkaraAges 18–90 - NCT07296081Recruiting
PET scan study for heart scarring in heart failure
This study uses a special PET scan to look for scarring (fibrosis) in the heart muscle of people with heart failure. It may help doctors better understand why some hearts get stiff or weak.
Coimbra, Coimbra DistrictAges 18 years+ - NCT07104058Recruiting
FAPI PET scan to predict relapse in IgG4-RD
This study tests whether a special PET scan (FAPI PET/CT) can detect tiny signs of disease activity (MRD) in people with stable IgG4-RD, and whether it helps predict who might relapse.
Beijing, Beijing MunicipalityAges 18–75 - NCT04499365RecruitingEarly Phase 1
PET scan for detecting different cancer types
This trial uses a special PET scan to see how well it can find and track different types of cancer. It may help doctors better understand your cancer.
Fuzhou, FujianAges 18–90 - NCT07478523RecruitingPhase 2
FAPI-PET scan for initial screening of pancreatic and bile duct cancers
This trial tests a new imaging method called FAPI-PET to see if it can better detect pancreatic and bile duct cancers at an early stage. It may help doctors decide on the best treatment plan for you.
PessacAges 18 years+ - NCT06653452Recruiting
PET/MRI for rectal cancer treatment response
This study uses a special scan called PET/MRI to see how well treatment works for locally advanced rectal cancer before surgery. It may help doctors choose the best treatment plan for you.
Beijing, Beijing MunicipalityAges 18–75
What 68Ga-FAPI is being studied for
Conditions with recruiting 68Ga-FAPI studies.
Common questions
- Are there clinical trials studying 68Ga-FAPI?
- Yes. Clin2 currently lists 37 recruiting studies that include 68Ga-FAPI, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a 68Ga-FAPI trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is 68Ga-FAPI an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether 68Ga-FAPI or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.